Logo
Menu
Overview

Summary

Contact details

Officers6

Related companies2

FAQ

Find out all the information about LABORATE PHARMACEUTICAL NIGERIA LIMITED
by getting full access

Last updated: Jun 15, 2024

LABORATE PHARMACEUTICAL NIGERIA LIMITED

Cancel

is inactive

Private company limited by shares

Nigeria 09 Oct 2002 (22 years ago)

Share viaTwitterFacebookLinkedin

Summary

NameLABORATE PHARMACEUTICAL NIGERIA LIMITED
Status
  • ActiveInactive
JurisdictionActiveNigeria
Registration number (RC)CodeRC-462858
Registry number462858
Incorporation Date09 Oct 2002 (22 years ago) / 58 companies with the same date
Paid share capital200000 NGN
Value of shares1 NGN
Shares issued200000
Legal formPrivate company limited by shares
Type of activity

Contact details

Legal addressNO 128, MIKE AJEGBO ROAD, OBOSI, ANAMBRA STATE

Officers

individual

IndividualNigeria

Sir Obi Nnamdi

Shareholder


Type of sharesOrdinary

Number of shares30000

Country of residenceNIGERIA

individual

IndividualNigeria

Mr Obi Chidi

Shareholder


Type of sharesOrdinary

Number of shares30000

Country of residenceNIGERIA

individual

IndividualNigeria

Okoroafor Reliance

Presenter


Appointed on09 Jan 2022

Country of residenceNIGERIA

individual

IndividualNigeria

Sir Obi Nnamdi

Director


Country of residenceNIGERIA

individual

IndividualNigeria

Justitia Attorneys Justitia

Secretary


Country of residenceNIGERIA

Get ahead with complete company information - register now.

Join the 50,000+ businesses already using B2BHint.

Sign up

Frequently asked questions

Where is LABORATE PHARMACEUTICAL NIGERIA LIMITED's headquarters?

LABORATE PHARMACEUTICAL NIGERIA LIMITED's headquarters is located at NO 128, MIKE AJEGBO ROAD, OBOSI, ANAMBRA STATE

What is LABORATE PHARMACEUTICAL NIGERIA LIMITED's industry?

LABORATE PHARMACEUTICAL NIGERIA LIMITED is in the industry of Pharmaceutical Services

What year was LABORATE PHARMACEUTICAL NIGERIA LIMITED started?

LABORATE PHARMACEUTICAL NIGERIA LIMITED was started in 2002

Sources: Corporate Affairs Commission